Features

Features

Debates, in-depth articles, and surprising profiles from ASH Clinical News

Dr. Schenkein biking in Miami.

Pulling Back the Curtain: David Schenkein, MD

In this edition, David Schenkein, MD, walks us through the three stages – and counting – of his career. Hear more from our interview with Dr....
Alexis Thompson, MD, MPH and Thomas Coates, MD

Are New Treatment Options for Beta Thalassemia Ready for Widespread Use?

Patients with transfusion-dependent beta thalassemia, the most severe form of the disease, require lifelong management with red blood cell (RBC) transfusions, presenting a substantial...
In Myleloma, New Drugs, Skyrocketing Price Tags

In Myeloma, New Drugs, Skyrocketing Price Tags

In late February, seven pharmaceutical executives were called before the U.S. Senate Finance Committee to testify about the prices of brand-name prescription drugs, which...

Pulling Back the Curtain: Clara Bloomfield, MD

In this edition, Clara Bloomfield, MD, talks about being on the right project at the right time and having academia in her blood.Where did...

Resurrecting the House Call

New at-home strategies for hematologic conditions offer improved outcomes and patient satisfaction Physician home visits have become a thing of the past: Nearly a century...

International Partnerships Lead to Strides in Pediatric Leukemia in El Salvador

Although acute lymphocytic leukemia (ALL) is relatively rare, it is the most common cancer diagnosed in children, representing approximately one-quarter of cancers diagnosed in...

Demystifying Genetic Testing for Bleeding Disorders

When hemophilia and von Willebrand disease (vWD) were first recognized, doctors didn’t diagnose a patient until he (or, much more infrequently, she) experienced a...

CMML: A Unique Overlap Syndrome Receiving Increased Attention

For many years, chronic myelomonocytic leukemia (CMML) has been treated as a form of myelodysplastic syndrome (MDS), despite its unique clinical and biological characteristics. “Everyone...

New Treatment Options Lead to New Questions in Acute Myeloid Leukemia

For the past 40 years, the standard remission induction treatment for patients with newly diagnosed acute myeloid leukemia (AML) who are candidates for intensive...

Raising the Barre: Kimberly Stegmaier, MD

In this edition, Kimberly Stegmaier, MD, discusses her passion for ballet.What was your first experience with ballet? I grew up in Long Island and my...
Advertisement

Current Issue

June 2019, Volume 5, Issue 7

This issue features a debate about new treatment options for beta-thalassemia, a look at what’s driving skyrocketing drug prices in myeloma, and more.